Comparative analysis of second and third-generation nanobody-based CAR-NK cells targeting PSMA in prostate cancer immunotherapy: In silico and in vitro studies

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 114

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-7_015

تاریخ نمایه سازی: 1 تیر 1405

چکیده مقاله:

Objective(s): The use of CAR technology in the treatment of cancer cells is progressing, as well as the use of CAR T-cell in the treatment of blood malignancies is in the clinical trial stage.  In this study, have compared the second and third generation CAR expressed in NK cells in dealing with prostate cancer cells. Materials and Methods: To optimize the CAR design for detection of NK-۹۲ cells, an in silico approach to select between two tags (Flag and c-Myc tags) was initially employed, ultimately favoring the Flag tag. By using lentiviral particles, transduced NK-۹۲ cells with second- and third-generation CAR constructs were subsequently tested as effector cells against prostate cancer cells expressing the Prostate-Specific Membrane Antigen (PSMA). Then assessed both cytokine secretion and cytotoxic responses. Results: Computational analysis indicated that the NB/Flag/hinge configuration would provide superior PSMA recognition. Flow cytometry confirmed successful CAR expression in ۴۷% of second-generation and ۴۹% of third-generation NK-۹۲ cells. Upon co-culture with PSMA-positive LNCaP cells and PSMA-negative PC-۳ cells, the third-generation CAR NK cells demonstrated a noticeably stronger cytotoxic effect. Furthermore, higher levels of IL-۲, TNF-α, and IFN-γ secretion were observed in the third-generation CAR group compared to the second.Conclusion: According to the computational studies, NB/Flag/hinge interacts with PSMA primarily through electrostatic forces. More importantly, third-generation CAR NK cells targeting PSMA displayed enhanced cytotoxicity and cytokine production relative to second-generation counterparts, pointing to their greater potential for therapeutic application.

کلیدواژه ها:

Chimeric antigen receptor ، Natural killer cell ، Single-domain antibodies (Nanobodies) ، Prostate-specific membrane antigen (PSMA) ، Prostatic Neoplasms ، OX۴۰ co-stimulatory domain ، Molecular dynamics - Simulation

نویسندگان

Masoud Gandomkar Ghalhar

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Arezoo Karami Vandishi

Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Akram Ramazani

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Fatemeh Hajari Taheri

Food and Drug Laboratory Research Center (FDLRC), Iran Food and Drug Administration (IFDA), MOH & ME, Tehran, Iran

Zahra Sharifzadeh

Hybridoma Lab, Department of Immunology, Pasteur Institute of Iran, Tehran, Iran

Mohsen Abolhassani

Hybridoma Lab, Department of Immunology, Pasteur Institute of Iran, Tehran, Iran

Masoud Soleimani

Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Niloofar Taghipour

Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Wytske M van Weerden

Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands

Mojgan Bandehpour

Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mahmoud Hassani

Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Kowsar Bagherzadeh

Eye Research Center, Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :